Equity Overview
Price & Market Data
Price: $2.44
Daily Change: +$0.08 / 3.28%
Daily Range: $2.44 - $2.59
Market Cap: $88,312,090
Daily Volume: 2,079
Performance Metrics
1 Week: 0.54%
1 Month: 9.42%
3 Months: 69.44%
6 Months: 15.09%
1 Year: -4.84%
YTD: 29.10%
Company Details
Employees: 60
Sector: Health technology
Industry: Biotechnology
Country:
Details
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.